drugset / Trial / NCT03119194
Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067
NaSingle-groupOpen-labelTreatment
Summary
The purpose is to and to assess the mass balance recovery after a single oral dose of \[14C\]-BIA 9-1067 and to provide plasma, urine and faecal samples for metabolite profiling and structural identification.
Timeline
- Start
- 2017-01-27
- Primary completion
- 2017-04-27
- Completion
- 2017-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 100 mg | Oral |